Executive Decisions Roundup
This article was originally published in The Tan Sheet
Another Coca-Cola exec pops up at NBTY; Hussain helms Glaxo pharma globally; China TCM office veteran returns; T-Bird tabs Huang as COO; and Lee named Calif. DTSC director.
You may also be interested in...
Steven Cahillane, who left his post as president of Coca-Cola Co.’s Americas division in 2013, is moving to NBTY to replace Jeffrey Nagel after the supplement manufacturer and retailer reported flat sales for its most recent earnings period and after net income dropped nearly 12% during the firm’s previous fiscal year.
Granger’s exit means House Appropriations will have different chair no matter which party wins majority 2024 elections; Democrats will lose senior House Energy and Commerce Health Subcommittee member with Eshoo’s retirement.
FTC and California Attorney General offer CRI Genetics LLC as exhibit A for making good on promised deliverables for DNA-based ancestry and information reports.